Sino Biopharmaceutical Limited (HKG: 1177)

Sino Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	68,999	63,845	84,459	102,408	140,925	136,693
Market Cap Growth	-39.73%	-24.41%	-17.53%	-27.33%	3.10%	110.43%
Enterprise Value	75,203	66,382	90,167	114,126	146,103	139,402
Last Close Price	3.79	3.40	4.38	5.10	6.95	6.68
PE Ratio	30.38	24.53	31.85	5.67	39.69	40.66
PS Ratio	2.34	2.21	2.87	3.11	5.02	5.04
PB Ratio	1.96	1.52	1.97	2.21	5.29	5.94
P/FCF Ratio	11.16	11.60	14.88	22.84	30.42	31.53
P/OCF Ratio	7.04	9.55	11.92	15.55	22.28	22.95
EV/Sales Ratio	2.52	2.30	3.06	3.46	5.20	5.14
EV/EBITDA Ratio	11.01	9.45	12.75	17.05	21.73	19.86
EV/EBIT Ratio	12.79	11.08	14.81	20.07	30.02	25.16
EV/FCF Ratio	12.17	12.06	15.88	25.46	31.54	32.16
Debt / Equity Ratio	0.23	0.33	0.37	0.32	0.63	0.42
Debt / EBITDA Ratio	1.43	1.97	2.22	2.21	2.48	1.36
Debt / FCF Ratio	1.68	2.54	2.81	3.36	3.64	2.22
Asset Turnover	0.42	0.41	0.42	0.50	0.56	0.56
Inventory Turnover	2.72	2.31	2.10	2.79	2.93	3.44
Quick Ratio	0.94	0.90	1.15	1.38	1.87	2.76
Current Ratio	1.15	1.05	1.29	1.53	2.08	3.07
Return on Equity (ROE)	12.87%	12.12%	11.94%	55.25%	20.20%	16.48%
Return on Assets (ROA)	5.54%	5.33%	5.40%	5.37%	6.05%	7.09%
Return on Capital (ROIC)	7.35%	6.60%	6.60%	6.69%	7.78%	8.83%
Earnings Yield	8.98%	4.02%	3.40%	17.51%	2.34%	2.26%
FCF Yield	12.62%	8.62%	6.72%	4.38%	3.29%	3.17%
Dividend Yield	1.58%	1.47%	2.74%	1.57%	1.05%	0.80%
Payout Ratio	15.47%	27.13%	49.84%	6.42%	42.84%	29.68%
Buyback Yield / Dilution	2.25%	2.57%	1.38%	-2.57%	0.06%	-1.42%
Total Shareholder Return	3.84%	4.04%	4.12%	-1.00%	1.11%	-0.62%

Source: S&P Capital IQ. Standard template. Financial Sources.